Clinical trials
Phase 3 Multiple Sclerosis, Relapsing-Remitting trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2006 | 2 |
| 2007 | 3 |
| 2008 | 1 |
| 2009 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Biogen | 5 |
| Bayer | 2 |
| Genzyme, a Sanofi Company | 2 |
| Hoffmann-La Roche | 2 |
| Amsterdam UMC, location VUmc | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Novartis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis, Relapsing-Remitting | 14 |
| Multiple Sclerosis | 7 |
| Recurrence | 2 |
| Autoimmune Diseases of the Nervous System | 1 |
| Demyelinating Autoimmune Diseases, CNS | 1 |
| Demyelinating Diseases | 1 |
| Nervous System Diseases | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.